On Monday, Replimune Group Inc (NASDAQ: REPL) opened lower -6.16% from the last session, before settling in for the closing price of $10.39. Price fluctuations for REPL have ranged from $4.92 to $17.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 11.67% at the time writing. With a float of $61.87 million, this company’s outstanding shares have now reached $77.01 million.
Let’s determine the extent of company efficiency that accounts for 331 employees. In terms of profitability, gross margin is 65.59%, operating margin of -5963.83%, and the pretax margin is -5634.14%.
Replimune Group Inc (REPL) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Replimune Group Inc is 19.67%, while institutional ownership is 88.65%. The most recent insider transaction that took place on Dec 16 ’24, was worth 124,200. In this transaction Chief Executive Officer of this company sold 10,000 shares at a rate of $12.42, taking the stock ownership to the 202,014 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Chief Strategy Officer proposed sale 15,000 for $12.57, making the entire transaction worth $188,550.
Replimune Group Inc (REPL) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.91% during the next five years compared to -19.52% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Check out the current performance indicators for Replimune Group Inc (REPL). In the past quarter, the stock posted a quick ratio of 11.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.14, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.74 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Looking closely at Replimune Group Inc (NASDAQ: REPL), its last 5-days average volume was 0.55 million, which is a drop from its year-to-date volume of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 11.33%. Additionally, its Average True Range was 0.72.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 2.29%, which indicates a significant decrease from 5.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.62% in the past 14 days, which was lower than the 76.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.59, while its 200-day Moving Average is $11.36. However, in the short run, Replimune Group Inc’s stock first resistance to watch stands at $10.10. Second resistance stands at $10.45. The third major resistance level sits at $10.71. If the price goes on to break the first support level at $9.49, it is likely to go to the next support level at $9.23. Should the price break the second support level, the third support level stands at $8.88.
Replimune Group Inc (NASDAQ: REPL) Key Stats
There are currently 77,015K shares outstanding in the company with a market cap of 750.89 million. Presently, the company’s annual sales total 0 K according to its annual income of -215,790 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -66,340 K.
